218. アルポート症候群 Alport syndrome Clinical trials / Disease details
臨床試験数 : 30 / 薬物数 : 36 - (DrugBank : 15) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 46
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05655728 (ClinicalTrials.gov) | January 3, 2023 | 8/12/2022 | Treatment With Metformin in Chinese Children With Alport Syndrome | Efficacy and Safety of Metformin in Alport Syndrome: A Randomized, Double-blind, Placebo-controlled Study in China | Alport Syndrome;Metformin | Drug: Metformin;Other: Placebo | Peking University First Hospital | NULL | Not yet recruiting | 10 Years | 18 Years | All | 78 | Phase 4 | NULL |